Navigation Links
Varespladib Receives 2010 European Society Pediatric Research Award
Date:12/7/2010

es interest for pediatricians from primary care, general pediatric practice and specialty practice with a program for intensive care and general pediatric nursing. 

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. Anthera has one Phase 3 clinical program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as sPLA2 . Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease (CAD). Anthera's Phase 2 product candidate, A-623, targets elevated levels of B-lymphocyte stimulator (BAFF) which has been associated with a variety of B-Cell mediated autoimmune diseases, including systemic lupus erythematosus (lupus). For more information, please visit www.anthera.com.

Safe Harbor Statement

Certain statements contained in this press release that refer to future events are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on Anthera's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially as set forth in the Company's public filings with the Securities and Exchange Commission, including Anthera's Quarterly Report on Form 10-Q for the quarter ended September 30, 2010. Anthera disclaims any intent or obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law.

CONTACT: Bianca Nery of A
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
2. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
3. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
4. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
5. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
10. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
11. CryoCor Receives FDA Approval for Right Atrial Flutter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014   Ventana Medical Systems, Inc.  (Ventana), a ... entered into an agreement with Merck KGaA, Darmstadt, ... in the United States and ... KGaA,s biopharmaceutical division on the development and commercialization of ... Ventana,s proprietary diagnostic assays. In alignment with Merck KGaA,s ...
(Date:7/10/2014)... 2014   LabStyle Innovations Corp . (OTCQB:DRIO), developer ... the appointment of Professor Richard B. Stone ... of Directors. Prof. Stone brings over ... LabStyle as an entrepreneur, venture capitalist public, company ... expert. He currently serves on the board of ...
(Date:7/10/2014)... Decision Resources Group finds that over half ... and Drug Administration,s (FDA) approval of Vifor Fresenius Medical ... approved by the FDA in November 2013 for the ... on dialysis. Other key findings from the ... : , Bundling: ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... , July 30 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, today announced that on July ... LLC, stating that PharmAthene is not in compliance with the continued ... NYSE Amex Company Guide, because it has stockholders, equity of less ...
... 30 Conatus Pharmaceuticals Inc. announced today that Conatus ... disclosed.  Conatus Pharmaceuticals is a privately-held drug development company focused on liver ... , ... Ph.D., the former CEO of Idun Pharmaceuticals, which was acquired by Pfizer ...
Cached Medicine Technology:PharmAthene Provides Update on NYSE Amex Listing Compliance Plan 2PharmAthene Provides Update on NYSE Amex Listing Compliance Plan 3Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary 2
(Date:7/13/2014)... 13, 2014 Celebrity fitness trainer and ... a promotional partnership with Aqua Health Labs for their ... EPA supplement . The collaboration was recently announced live ... fitness trainer , actor, model, and a two time ... A-List celebrities, he has prepared stars including Demi Moore, ...
(Date:7/13/2014)... 13, 2014 If Dr. Lawrence Power has ... just launched at http://www.HealthYourself101.com will expand people’s understanding ... , Power has set out to provide a health education ... actually – dare we say it? – entertaining to dig ... “aims to engage the remote learner – the solitary individual ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Recently, iFitDress.com, ... and women’s special occasion outfits, has added a new ... website. Furthermore, the company has launched a promotion for ... discount. , iFitDress.com is now providing thousands of ... products sell well in Britain, America, France, Italy and ...
(Date:7/12/2014)... iFitDress.com, one of the world’s leading wedding dress suppliers, has ... What’s more, all these hot outfits are available at discounted ... states, “We are proud to announce our new red evening ... experience. In addition to the big discounts, low shipping costs ... always mean bad quality. All the red evening gowns are ...
(Date:7/12/2014)... 12, 2014 Fresh off their respective performances ... will meet on September 5th at Sun Life Stadium in ... see some of the brightest stars in the world of ... Miami will be treated to some of the best talent ... ranked as the third best team in the world according ...
Breaking Medicine News(10 mins):Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:New and Beautiful Evening Dresses Unveiled by iFitDress.com 2Health News:Discounted Red Evening Gown Announced by iFitDress.com 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 3
... Invaluable Resource for Millions Who Want the Tax ... 2008, MILWAUKEE, Dec. 4 Consumers looking for ... advantage of health plans with,health savings accounts (HSAs) that ... site, http://www.HSAInsights.com, provides consumers and,employers with information ...
... 4 Selective Insurance,Group, Inc. announced the following ... ("Selective"):, Michael H. Lanza (Sparta, NJ), to ... Selective in 2004 as senior vice president and,general ... also,served as executive vice president and corporate secretary ...
... Industry and Technology Partners to Maximize Customer Value in Sales ... ... BLOOMFIELD HILLS, Mich., Dec. 4 gloStream, Inc.,(gloStream), an electronic ... formation of its,nationwide, multifaceted gloStream Certified Partner Network. The company,will deliver ...
... and alternative medicines (CAM) training for students in ... balanced, evidence-based advice to patients. , Dr ... of Pharmacy, has found CAM education integrated into ... attitudes. , A survey and interviews of ...
... athletes - often perceived as the epitome of health and ... are therefore proving useful in helping scientists understand more about ... at Griffith University, has enlisted elite rowers to help him ... barrier to infectious agents such as respiratory viruses. , ...
... release is also availabe in German . ... scientists at the Max Planck Institute for Evolutionary Anthropology ... 100,000 year old Belgian Neanderthal (Homo neanderthalensis). The report, ... USA (online edition early December), details how the team ...
Cached Medicine News:Health News:Video: New Web Site Helps Consumers and Employers Make Smart Choices on Health Savings Accounts (HSAs) 2Health News:Selective Insurance Group Announces Officer Appointments 2Health News:gloStream, Inc., Announces Formation of Nationwide Certified Partner Network 2Health News:gloStream, Inc., Announces Formation of Nationwide Certified Partner Network 3Health News:Complementary medicines training provides balance, not bias 2Health News:Exercising our immune system 2Health News:Neanderthal bearing teeth 2